XML 12 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Balance at Dec. 31, 2022 $ 224,519 $ 0 $ 690,762 $ (468) $ (465,775)
Balance, Shares at Dec. 31, 2022   4,047,531      
Stock-based compensation 40,779   40,779    
Issuance of common stock, upon vesting of restricted stock, Shares   40,065      
Purchase of common stock under the 2020 Employee Stock Purchase Plan 326   326    
Purchase of common stock under the 2020 employee stock purchase plan, Shares   5,836      
Issuance of common stock in public offering, net of underwriting discounts, commissions and offering costs and registered direct offering, net of issuance costs 70,169 $ 0 70,169    
Issuance of common stock in public offering, net of underwriting discounts, commissions and offering costs and registered direct offering, net of issuance costs, Shares   869,565      
Unrealized (loss) gain on available-for-sale securities 406     406  
Net Income (Loss) (190,418)       (190,418)
Balance at Dec. 31, 2023 145,781 $ 0 802,036 (62) (656,193)
Balance, Shares at Dec. 31, 2023   4,962,997      
Stock-based compensation 26,347   26,347    
Issuance of common stock, upon vesting of restricted stock, Shares   76,061      
Purchase of common stock under the 2020 Employee Stock Purchase Plan 21   21    
Purchase of common stock under the 2020 employee stock purchase plan, Shares   1,582      
Unrealized (loss) gain on available-for-sale securities (73)     (73)  
Net Income (Loss) (58,769)       (58,769)
Balance at Dec. 31, 2024 $ 113,307 $ 0 $ 828,404 $ (135) $ (714,962)
Balance, Shares at Dec. 31, 2024   5,040,640